BioMarin Pharmaceutical Inc.
MX ˙ BMV ˙ US09061G1013
SecurityMX:BMRN / BioMarin Pharmaceutical Inc.
InstitutionTwin Tree Management, LP
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Twin Tree Management, LP ownership in BMRN / BioMarin Pharmaceutical Inc.

On November 13, 2025 - Twin Tree Management, LP filed a 13F-HR form disclosing ownership of 0 shares of BioMarin Pharmaceutical Inc. (MX:BMRN) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on July 28, 2025 disclosing 10,703 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -100.00% during the quarter.

Twin Tree Management, LP has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 21,100 of underlying shares valued at $1,191,939 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-13 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -10,703 -100.00 0 -100.00
2025-07-28 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,703 -40,577 -79.13 588 -83.77 0.0011
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 51,280 51,280 3,625 0.0068
2024-11-13 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -34,022 -100.00 0 -100.00
2024-08-13 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,022 29,986 742.96 2,801 695.74 0.0063
2024-05-09 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,036 -55,649 -93.24 353 -93.88 0.0008
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 59,685 12,932 27.66 5,755 39.12 0.0110
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 46,753 46,753 4,137 0.0093
2023-05-10 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -67,022 -100.00 0 -100.00
2023-02-13 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 67,022 35,714 114.07 6,936 161.34 0.0150
2022-11-10 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,308 11,540 58.38 2,654 62.03 0.0051
2022-08-11 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,768 -6,114 -23.62 1,638 -17.94 0.0026
2022-05-11 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,882 -9,373 -26.59 1,996 -35.92 0.0032
2022-02-10 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 35,255 35,255 3,115 0.0065
2021-11-12 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -11,701 -100.00 0 -100.00
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,701 5,507 88.91 976 108.55 0.0026
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,194 -35,784 -85.24 468 -87.29 0.0017
2021-02-12 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 41,978 23,814 131.11 3,681 166.35 0.0147
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,164 -34,830 -65.72 1,382 -78.86 0.0057
2020-08-12 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 52,994 52,994 6,536 0.0266
2019-08-12 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -401 -100.00 0 -100.00
2019-05-10 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 401 401 36 0.0002
2018-08-07 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -534 -100.00 0 -100.00
2018-05-09 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 534 534 43 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 21,100 -61.57 1,192 -63.49 n/a n/a n/a
2026-02-11 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 54,900 121.37 3,263 142.89 n/a n/a n/a
2025-11-13 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 24,800 275.76 1,343 270.99 n/a n/a n/a
2025-07-28 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 6,600 363 n/a n/a n/a
2024-05-09 2024-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 7,200 694 n/a n/a n/a
2023-08-11 2023-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-10 2023-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 18,100 -38.23 1,760 -41.95 n/a n/a n/a
2023-02-13 2022-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 29,300 3,032 n/a n/a n/a
2022-08-11 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-11 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 5,400 416 n/a n/a n/a
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 4,300 325 n/a n/a n/a
2021-02-12 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 8,800 670 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 7,800 -77.13 464 -74.92 n/a n/a n/a
2025-11-13 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 34,100 0.00 1,847 -1.49 n/a n/a n/a
2025-07-28 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 34,100 1,874 n/a n/a n/a
2025-02-10 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-13 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 6,400 -63.64 450 -69.01 n/a n/a n/a
2024-08-13 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 17,600 -91.32 1,449 -91.82 n/a n/a n/a
2024-05-09 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 202,800 -37.48 17,713 -43.37 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 324,400 31,279 n/a n/a n/a
2022-08-11 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-11 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 10,000 -13.79 771 -24.78 n/a n/a n/a
2022-02-10 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 11,600 107.14 1,025 136.72 n/a n/a n/a
2021-11-12 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 5,600 433 n/a n/a n/a
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 6,000 33.33 453 14.68 n/a n/a n/a
2021-02-12 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 4,500 -52.63 395 -45.37 n/a n/a n/a
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 9,500 723 n/a n/a n/a
2018-08-07 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-09 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 2,000 162 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.